CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for ...
Phase 3
Louisville, Kentucky, United States and 197 other locations
and capecitabine monotherapy in patients with metastatic pancreatic adenocarcinoma whose disease has not progressed on a first line fluoropy...
Phase 1, Phase 2
Louisville, Kentucky, United States and 18 other locations
The aim of this study is to characterize the safety and tolerability of MORAb-202, and to assess the objective response rate in participants with pre...
Phase 2
Louisville, Kentucky, United States and 32 other locations
first-line treatment of participants with locally advanced unresectable or metastatic gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...
Phase 3
Louisville, Kentucky, United States and 212 other locations
The purpose of this study is to confirm the recommended phase 2 dose (RP2D) of zolbetuximab in combination with Nab-P + GEM, determine overall surviv...
Phase 2
Louisville, Kentucky, United States and 137 other locations
This study is being done to see if tucatinib with trastuzumab, ramucirumab and paclitaxel works better than ramucirumab and paclitaxel to treat HER2-...
Phase 2, Phase 3
Louisville, Kentucky, United States and 47 other locations
unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma. Why is this study being done? SPOTLIGHT is a new clinical st...
Phase 3
Louisville, Kentucky, United States and 219 other locations
The purpose of this study is to assess the efficacy and safety of lenvatinib (E7080/MK-7902) plus pembrolizumab (MK-3475) plus chemotherapy compared...
Phase 3
Louisville, Kentucky, United States and 176 other locations
Subjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT). There will be 2 study...
Phase 3
Louisville, Kentucky, United States and 5 other locations
A phase IIb, open-label, randomized study of Nab-Paclitaxel and Gemcitabine and plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer
Phase 2
Louisville, Kentucky, United States and 16 other locations
Clinical trials
Research sites
Resources
Legal